Breast reconstructions are performed in both community and academic surgical practices. The chief aim of this project is to determine the differences in medical comorbidities, reconstructive modalities, payer status, and surgical outcomes between practice settings.
regain candidacy on the renal transplant waiting list. We previously published our results of 21 patients in 2015, here we present our updated 10-year experience.
METHODS:
We performed a retrospective review of all patients deemed high-risk for post-kidney transplant wound complications who underwent panniculectomy in preparation for renal transplantation at our institution from 2008 to 2018. All patients had a minimum of 3 months follow-up. Patient characteristics (age, BMI, medical comorbidities, maximum BMI and weight lost prior to panniculectomy) and surgical outcomes (specimen weight, operation length, time to drain removal, wound complications, time to treat complication) were analyzed after panniculectomy as well as after transplantation.
RESULTS:
We performed 60 panniculectomies in renal transplant candidates. Wound complications occurred in 29 patients (48%). Minor wound complications (wound separation, cellulitis, skin necrosis) occurred in 21 patients (35%), major wound complications (hematoma, seroma, abscess, unplanned return to the operating room) occurred in 10 patients (17%). 30 patients have since undergone renal transplantation. No patients have had post-transplant wound healing complication.
CONCLUSION:
Panniculectomy in preparation for renal transplantation can be performed in patients with end-stage renal disease with a high but manageable complication rate, converting previously ineligible patients into eligible candidates for kidney transplantation. These wound complications are more easily managed prior to institution of immunosuppression required for renal transplant. While performing panniculectomies in these high-risk patients clearly shifts the burden of complications from Transplant Surgery to Plastic Surgery, it improves patient access to a life-extending procedure, further supporting Plastic Surgery's vital role in our comprehensive healthcare system.
METHODS:
All patients undergoing breast reconstruction from 2013-2018 were included. Collected data included reconstructive modality, medical comorbidities, payer status, and complication profiles. Results were further subdivided to evaluate academic versus community plastic surgeons.
RESULTS:
One thousand and forty-five patients (1,683 breasts) underwent breast reconstruction during the study period. Fifty two point eight percent were performed by surgeons in academic practice while (47.2%) were performed by surgeons in a community-based practice. Patients in the academic setting had a 5.5% greater prevalence of any psychiatric diagnosis (p=0.004), and 7.1% more frequent history of prior open abdominal surgery (p<0.001) and 2.6% increased prevalence of diabetes (p=0.064). Outcomes were similar between the groups except for higher infection rates (p=0.027) and implant removal rates (p=0.003) in the community cohort. When evaluating insurance status, the academic plastic surgery cohort had 30.5% fewer patients with commercial insurance, 16.7% more patients with Medicaid, and 6.1% more patients with Medicare (p<0.001).
CONCLUSIONS:
Within our institution, academic and community-based plastic surgeons perform breast reconstruction with similar complication profiles. Patients treated by academic surgeons have a higher rate of pre-operative medical and psychiatric comorbidities as well as higher percentages of Medicaid and Medicare. Patients treated by community surgeons have higher rates of infection and implant explant in addition to higher proportions of commercial insurance.
facilities have been described. The impact of insurance on breast reconstruction modalities when access to care is controlled is unknown.
METHODS:
Records and outcomes for patients who underwent breast reconstruction at an academic medical center between 2013 and 2017 were reviewed. Reconstructive modalities were compared across insurance sub groups using chi-squared analysis while logistic regressions analyzed the impact of insurance on reconstruction.
RESULTS: 1683 breast reconstructions were analyzed with a mean age of 49.8 years and BMI of 27.9. The commercially insured were more likely to undergo microvascular autologous breast reconstruction (44.4% vs. 31.3%, p<0.001) with an odds ratio of 2.22 while patients with Medicare and Medicaid were significantly more likely to receive tissue expander/implant breast reconstruction with an odds ratio of 1.42 (41.7% vs. 47.7%, p=0.013). Comparing all patients with microvascular reconstruction, the commercially insured were more likely to receive a perforator flap (79.7% vs. 55.3% vs. 43.9%) with an odds ratio of 4.23 (p<0.001). When stratifying patients by median household income, the highest income quartile was most likely to receive a perforator flap (82.1%) (p<0.001) while the lowest income quartile was most likely to receive a muscle-sparing TRAM flap (36.4%) (p<0.001).
CONCLUSIONS:
Patients at the same academic medical center had significantly different breast reconstruction modalities when stratified by insurance and household income. Despite similar access to care, differences in insurance types may favor higher rates of perforator flap breast reconstruction among the commercially insured.
